| http://www.w3.org/ns/prov#value | - Centrally acting sympatholytic agents such as -adrenoceptor agonists or imidazoline receptor agonists are well known to reduce the BP [72], but adverse effects such as drowsiness and dry mouth limit their usage. -Adrenoceptor antagonists are also used for the treatment of hypertension [73] and are known to act at the CNS level to decrease SNSA in rats [74].
|
